Thermo Fisher Scientific (NYSE:TMO) Stock Upgrade
The previous rating for shares of Thermo Fisher Scientific (NYSE:TMO) has been supplanted by today’s new rating by Goldman Sachs, who upgraded shares to a “Americas Conviction Buy List”.
From a total of 16 analysts covering Thermo Fisher Scientific (NYSE:TMO) stock, 19 rate it a ”Buy”, 0 a “Sell”, and 1 a ”Hold”. This means that 95% of the ratings are positive. The highest target price is $165 while the lowest target price is $137.5. The mean of all analyst targets is $153.41 with a 10.15% above today’s ($136.05) stock price. Thermo Fisher Scientific was the topic of 8 analyst reports since July 24, 2015 according to the firm StockzIntelligence Inc. Goldman Sachs upgraded shares on December 8 to “Americas Conviction Buy List” rating. Mizuho maintained TMO stock in a recent report from July 23 with “Buy” rating.
The stock increased 0.38% or $0.52 during the last trading session, striking $136.05. Approximately 1.55 million shares of stock traded hands. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 6.57% since May 6, 2015 and is uptrending. It has outperformed by 7.37% the S&P500.
The overall sentiment of institutions has increased to 1.08 in Q2 2015. Its up 0.15, from 0.93 in 2015Q2. The ratio improved, as 65 institutions have sold all the shares of Thermo Fisher Scientific Inc. that they owned while 320 funds have taken shares off the table. 68 funds have purchased shares for the first time while 349 added to their positions. These institutions now hold 327.50 million shares or 5.82% less than the 347.72 million shares they owned in 2015Q2.
The Fund Cryder Capital Partners Llp currently is holding shares equating to 10.78% of its total portfolio in Thermo Fisher Scientific Inc. representing a total of 136,458 shares. Another fund,Robecosam Usa Inc., is holding a total of 49,607 shares equating to 8.75% of their holdings. Additionally, Grand Jean Capital Management Inc has a 129,406 share stake in Thermo Fisher Scientific Inc. which represents 7.17% of their total portfolio. The Fund, Caledonia Investments Plc, based out of United Kingdom, has also built up a stake in the stock, which represents a total of 6.02% of their total portfolio. Finally Agf Investments America Inc., a fund which is based in the state of Ontario – Canada reported a total holdings of 76,900 shares.
Insider activity is a very important aspect to track on any stock. Going back to February 25, 2015, shareholders of Thermo Fisher Scientific Inc. have witnessed 0 insider purchases, and a total of 4 sales equating to a net activity of approximately $5.51 million . Casper Marc N sold 25,000 shares worth approximately $3.25 million. Malus Alan J sold 4,557 shares worth approximately $581,245. Thomson Andrew J sold 5,000 shares worth approximately $676,158. Hornstra Peter E sold 7,381 shares worth approximately $1.00 million. The company insider Jacks Tyler sold 15,000 shares worth $1.95M.
Thermo Fisher Scientific Inc. is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company has a market cap of $54.09 billion.
According to Zacks Investment Research, “Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company’s four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, purity chemistry production, protein analysis, Ribonucleic acid (RNA)-interference techniques, immunodiagnos. Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.” Get a free copy of the Zacks research report on Thermo Fisher Scientific Inc. (TMO).